Elevated One-hour Post-load Plasma Glucose Levels Identifies Subjects with Normal Glucose Tolerance but Early Carotid Atherosclerosis
Overview
Authors
Affiliations
Objective: To examine whether individuals with normal glucose tolerance (NGT), whose 1-h post-load plasma glucose is >or=155 mg/dl, or with impaired glucose tolerance (IGT) have an increased carotid intima-media thickness (IMT), as compared with NGT individuals with 1-h post-load plasma <155 mg/dl.
Methods: Atherosclerosis risk factors, oral glucose tolerance test (OGTT), and ultrasound manual measurement of IMT were analyzed in 400 non-diabetic Caucasians.
Results: As compared with individuals with a 1-h post-load plasma glucose <155 mg/dl, NGT individuals with a 1-h post-load plasma glucose >or=155 mg/dl exhibited higher hsCRP (2.0+/-1.5 vs. 1.5+/-1.0, P=0.008), and IMT (0.82+/-0.20 vs. 0.71+/-0.16; P=0.006), and lower insulin sensitivity (71+/-39 vs. 105+/-57; P<0.0001), and IGF-1 levels (214+/-88 vs. 176+/-49; P<0.03). No significant differences were observed in metabolic and cardiovascular risk factors between IGT and NGT subjects with a 1-h post-load glucose >or=155 mg/dl. Of the three glycemic parameters, 1-h and 2-h post-load glucose, but not fasting glucose, were significantly correlated with IMT. In a stepwise multivariate regression analysis in a model including age, gender, and a variety of atherosclerosis risk factors, the three variables that remained significantly associated with IMT were age (P<0.0001), BMI (P<0.0001), and 1-h post-load glucose (P=0.02) accounting for 20.2% of its variation.
Conclusions: NGT subjects with a 1-h post-load glucose >or=155 mg/dl have an atherogenic profile similar to IGT individuals. These data suggest that a cutoff point of 155 mg/dl for the 1-h post-load glucose during OGTT may be helpful in the identification of NGT subjects at increased risk for cardiovascular disease.
Binge Eating Disorder and Metabolic Syndrome: Shared Mechanisms and Clinical Implications.
Alagha M, Al-Alam F, Saroufine K, Elias L, Klaimi M, Nabbout G Healthcare (Basel). 2025; 13(5).
PMID: 40077044 PMC: 11898466. DOI: 10.3390/healthcare13050482.
Teng L, Luo L, Sun Y, Wang W, Dong Z, Cao X Nutrients. 2025; 17(1.
PMID: 39796589 PMC: 11723153. DOI: 10.3390/nu17010152.
Insulin-like Growth Factor-Binding Protein-1 (IGFBP-1) as a Biomarker of Cardiovascular Disease.
Lewitt M, Boyd G Biomolecules. 2024; 14(11).
PMID: 39595651 PMC: 11592324. DOI: 10.3390/biom14111475.
A single bout of physical exercise improves 1-hour post-load plasma glucose in healthy young adults.
Moffa S, Sorice G, Giuseppe G, Cinti F, Ciccarelli G, Soldovieri L J Endocrinol Invest. 2024; 48(2):455-464.
PMID: 39347907 PMC: 11785650. DOI: 10.1007/s40618-024-02438-8.
Implementing care for women with gestational diabetes after delivery-the challenges ahead.
Eng P, Teo A, Yew T, Khoo C Front Glob Womens Health. 2024; 5:1391213.
PMID: 39221169 PMC: 11362992. DOI: 10.3389/fgwh.2024.1391213.